Literature DB >> 27693659

HCV and diabetes: towards a 'sustained' glycaemic improvement after treatment with DAAs?

C Fabrizio1, A Procopio1, L Scudeller2, R Dell'Acqua1, G Bruno1, E Milano1, M Milella1, A Saracino3, G Angarano1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2016        PMID： 27693659     DOI： 10.1016/j.cmi.2016.09.021

Source DB:  PubMed          Journal:  Clin Microbiol Infect        ISSN： 1198-743X            Impact factor:   8.067


× No keyword cloud information.
  8 in total

1.  No Improvement in Hemoglobin A1c Following Hepatitis C Viral Clearance in Patients With and Without HIV.

Authors:  Chloe S Chaudhury; Julia Sheehan; Cheryl Chairez; Elizabeth Akoth; Chloe Gross; Rachel Silk; Sarah Kattakuzhy; Elana Rosenthal; Shyam Kottilil; Henry Masur; Colleen Hadigan
Journal:  J Infect Dis       Date:  2017-12-27       Impact factor: 5.226

2.  Impact of DAA-Based Regimens on HCV-Related Extra-Hepatic Damage: A Narrative Review.

Authors:  Evangelista Sagnelli; Caterina Sagnelli; Antonio Russo; Mariantonietta Pisaturo; Clarissa Camaioni; Roberta Astorri; Nicola Coppola
Journal:  Adv Exp Med Biol       Date:  2021       Impact factor: 2.622

Review 3.  Endocrine disorders associated with hepatitis C virus chronic infection.

Authors:  Michele Colaci; Lorenzo Malatino; Alessandro Antonelli; Poupak Fallahi; Dilia Giuggioli; Clodoveo Ferri
Journal:  Rev Endocr Metab Disord       Date:  2018-12       Impact factor: 6.514

Review 4.  Current level of evidence on causal association between hepatitis C virus and type 2 diabetes: A review.

Authors:  Giacomo Gastaldi; Nicolas Goossens; Sophie Clément; Francesco Negro
Journal:  J Adv Res       Date:  2016-12-02       Impact factor: 10.479

5.  Glucose Metabolism Changes in Patients with Chronic Hepatitis C Treated with Direct Acting Antivirals.

Authors:  Sylvia Drazilova; Martin Janicko; Lubomir Skladany; Pavol Kristian; Marian Oltman; Maria Szantova; Dusan Krkoska; Eva Mazuchova; Lubica Piesecka; Veronika Vahalova; Marek Rac; Ivan Schreter; Ladislav Virag; Tomas Koller; Adriana Liptakova; Miriam Ondrasova; Peter Jarcuska
Journal:  Can J Gastroenterol Hepatol       Date:  2018-10-03

6.  Improvement of insulin sensitivity in diabetic and non diabetic patients with chronic hepatitis C treated with direct antiviral agents.

Authors:  Alessandro Gualerzi; Mattia Bellan; Carlo Smirne; Margherita Tran Minh; Cristina Rigamonti; Michela Emma Burlone; Ramona Bonometti; Sara Bianco; Azzurra Re; Serena Favretto; Giorgio Bellomo; Rosalba Minisini; Gian Piero Carnevale Schianca; Mario Pirisi
Journal:  PLoS One       Date:  2018-12-20       Impact factor: 3.240

Review 7.  Chronic Hepatitis C Association with Diabetes Mellitus and Cardiovascular Risk in the Era of DAA Therapy.

Authors:  Sylvia Drazilova; Jakub Gazda; Martin Janicko; Peter Jarcuska
Journal:  Can J Gastroenterol Hepatol       Date:  2018-08-13

8.  Impact of Treatment with Direct Acting Antiviral Drugs on Glycemic Control in Patients with Hepatitis C and Diabetes Mellitus.

Authors:  Pradeep Kumar Mada; Matthew E Malus; Arvin Parvathaneni; Bing Chen; Gabriel Castano; Sharon Adley; Maureen Moore; Michinari Hieda; Mohammed J Alam; Mark Feldman; John William King
Journal:  Int J Hepatol       Date:  2020-01-13
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.